Pamidronate-induced tubulointerstitial nephritis with Fanconi syndrome in a patient with primary hyperparathyroidism

Nephrol Dial Transplant. 2003 Apr;18(4):826-9. doi: 10.1093/ndt/gfg044.

Authors

Martin Buysschaert¹, Jean-Pierre Cosyns, Leonel Barreto, Michel Jadoul

Affiliation

¹ Department of Endocrinology and Nutrition, Cliniques Universitaires St Luc, Université Catholique de Louvain, Bruxelles, Belgium.

PMID: 12637657
DOI: 10.1093/ndt/gfg044

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Biopsy, Needle
Diphosphonates / adverse effects*
Diphosphonates / therapeutic use
Fanconi Syndrome / complications
Fanconi Syndrome / diagnosis*
Follow-Up Studies
Humans
Hyperparathyroidism / complications
Hyperparathyroidism / diagnosis
Hyperparathyroidism / drug therapy*
Immunohistochemistry
Male
Nephritis, Interstitial / chemically induced*
Nephritis, Interstitial / diagnostic imaging
Nephritis, Interstitial / pathology*
Pamidronate
Parathyroid Glands / pathology
Parathyroid Glands / surgery
Risk Assessment
Tomography, X-Ray Computed
Treatment Outcome
Ultrasonography, Doppler

Substances

Diphosphonates
Pamidronate